Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Solicitation opportunity was posted on February 5, 2014. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

NIMH Toxicological Evaluation of Novel Ligands Program

Closed
HHS-NIH-NIDA(MH)14-272Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The NIMH Toxicological Evaluation of Novel Ligands Program, identified by solicitation number HHS-NIH-NIDA(MH)14-272, is designed to accelerate the discovery and development of novel ligands for human imaging and psychoactive agents for clinical research and mental disorder treatments. This initiative serves as a critical resource that integrates with the Psychoactive Drug Screening Program and the Development of Novel PET and SPECT Ligands for Brain Imaging to create a rapid, cost-effective pipeline for pharmacological characterization and functional activity assessment in the central nervous system. Administered under NAICS code 541711, this award notice was posted on September 24, 2014. The program focuses on utilizing binding assays for receptors, channels, and transporters, as well as biochemical assays, to advance the application of these ligands in clinical studies. Bruce E. Anderson serves as the primary Contracting Officer for this initiative.

General Info

Agency

N/A

Contract Value

$0

NAICS

541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)

Place of Performance

Not specified

Set-Aside

NONE

Award Issued Date

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

2 updates
PhaseClosed
Posted

Presolicitation

Notice updated

The notice description changed.

Notice updated

Response deadline added: Feb 14, 2014. The notice description changed. The point of contact changed.

Type Changed

Presolicitation → Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts2 people available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Bruce E. AndersonContracting Officer
Melissa E. GluckContract Specialist

Full Description

Show more
The purpose of the NIMH Toxicological Evaluation of Novel Ligands Program is to accelerate the discovery, development, and application of novel ligands for imaging in humans. The program will also facilitate the discovery and development of novel psychoactive agents for clinical research and as potential therapeutic agents for the treatment of mental disorders. This initiative will provide a critical resource that complements NIMH's existing Psychoactive Drug Screening Program for pharmacological characterization of novel compounds in binding assays for receptors, channels, and transporters in the central nervous system and in biochemical assays to assess functional activity (http://pdsp.med.unc.edu/). The Toxicological Evaluation of Novel Ligands Program will also complement the initiative to accelerate the Development of Novel PET and SPECT Ligands for Brain Imaging (http://grants.nih.gov/grants/guide/pa-files/PA-13-157.html for use in human studies. Efforts of these activities will be coordinated to establish a pipeline for the rapid and cost-effective development of novel ligands for clinical studies of mental disorders.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS